• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT Back to Search Results
Model Number 6L45-22
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/08/2020
Event Type  malfunction  
Manufacturer Narrative
Patient information: pt#1 (b)(6)- year old male; pt#2 (b)(6) year old female; pt#3 (b)(6) year old male all available patient information is included.Additional patient details are not available.An evaluation is in process.A follow up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported false negative architect total bilirubin assay results for several patients.The customer alleges this issue to be associated with the onset of the use of a new lot of the total bilirubin calibrator (ln 01e66-04, lot 05647d01).The customer provided: pt#1 ((b)(6)- year old male): 20.2 umol/l, 12.922 umol/l; pt#2 ((b)(6)- year old female): 3.8 umol/l, 2.82 umol/l; pt# 3 ((b)(6)- year old male) 6.8 umol/l, 5.155 umol/l (reference range: 3.4 to 20.5 umol/l).There was no impact to patient management reported.
 
Manufacturer Narrative
The trend review by the product list number found no adverse trends related to this issue.A review of labeling address the customer issues.The labeling for the bilirubin calibrator and architect system was reviewed.The bilirubin calibrator package insert and architect operations manual provide adequate instructions for use of the assay as well as troubleshooting information intended to assist the operator with investigation of depressed results.There are lot to lot variation or differences between each bilirubin calibrator lot and each total bilirubin reagent lot produced.Each product must meet specifications prior to release for sale or distribution.Each product lot met expected specifications.No product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL BILIRUBIN
Type of Device
TOTAL BILIRUBIN REAGENT
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10548073
MDR Text Key207583335
Report Number3002809144-2020-00934
Device Sequence Number1
Product Code CIG
UDI-Device Identifier00380740174965
UDI-Public00380740174965
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 02/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/20/2021
Device Model Number6L45-22
Device Catalogue Number06L45-22
Device Lot Number56664UQ01
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/08/2020
Initial Date FDA Received09/17/2020
Supplement Dates Manufacturer Received02/03/2021
Supplement Dates FDA Received02/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC C16K PRC MOD, 03L77-01, (B)(6).; ARCHITECT C16000 ANALYZER; LN 03L77-01, SN (B)(6)
-
-